Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

Viceconti, Marco Hunter, Peter and Hose, Rod 2015. Big Data, Big Knowledge: Big Data for Personalized Healthcare. IEEE Journal of Biomedical and Health Informatics ...

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.79% higher to $477.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other biotech stocks. As we have mentioned in our article, “10 Best ...

companies can use predictive modeling to increase the probability of forecasting events, customer behavior, and financial, economic, and market risks. Companies can compile real-time data from ...

Choose a PBX system that checks all the boxes The best PBX system for your organization will depend on your business model and unique needs. Assess the cost of installation and the most important ...

The PostgreSQL community takes pride in releasing software that reliably stores your data. If you believe you've discovered a bug, please click the button below and follow the instructions on how to ...

While the MRG model is very accurate, the computing power needed to simulate neural responses limits its speed, creating a bottleneck that prevents MRG’s use in real-time modeling and slows research ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is a dominant force in the cystic fibrosis (CF) market, driven by its successful treatments like Trikafta, Kalydeco, and Symdeko. Trikafta has notably ...

In this article, we are going to take a look at where Vertex Pharmaceutical Inc. (NASDAQ:VRTX) stands against Jim Cramer's other go-to stocks for success. In a recent episode of Mad Money ...